Acquired Localized Hypertrichosis Induced by Rivastigmine

Table 1

Reported cases of adverse skin effects by rivastigmine.

	Gender	Age (years)	Route of administration	Latency time until the rash	Diagnosis	Evolution
Golüke et al. [8]	Male	74	Transdermal patch; (9.5 mg/day)	1 year	Localized allergic contact dermatitis	Drug discontinuation; Resolution in days; Recurrence with galantamine
Makris et al. [9]	Female	85	Transdermal patch; (9.5 mg/day); Oral; (6 mg/day)	3 weeks	Disseminated allergic contact dermatitis	Drug discontinuation; Resolution in 2 weeks
Allain-Veyrac et al. [10]	Male	88	Oral; (3 mg/day)	3 weeks	Baboon syndrome	Drug discontinuation; Resolution in 2 weeks
Greenspoon et al. [6]	Female	65	Transdermal patch; (Dose NA)	Several weeks	Disseminated allergic contact dermatitis	Drug discontinuation; Resolution in several weeks
Grieco et al. [7]	Male	75	Transdermal patch; (9.5 mg/day)	2 weeks	Disseminated allergic contact dermatitis	Drug discontinuation; Resolution time NA
Monastero et al. [11]	Female	73	Oral; (3 mg/day)	5 days	Baboon syndrome	Drug discontinuation; Resolution in 2 weeks

NA: not available.